Carmell (CTCXW) Competitors $0.11 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends CTCXW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CELUW, CEROW, and CINGWShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. Carmell vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate 180 Life Sciences (NASDAQ:ATNFW) and Carmell (NASDAQ:CTCXW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership. Does the MarketBeat Community believe in ATNFW or CTCXW? 180 Life Sciences and Carmell both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACarmellN/AN/A Is ATNFW or CTCXW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Carmell N/A N/A N/A Does the media refer more to ATNFW or CTCXW? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 equaled Carmell'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Very Positive Carmell Very Positive Which has preferable valuation and earnings, ATNFW or CTCXW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACarmell$12.32KN/AN/AN/AN/A SummaryCarmell beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCXW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCXW vs. The Competition Export to ExcelMetricCarmellBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$150.91M$5.15B$8.74BDividend YieldN/A3.64%5.18%4.08%P/E RatioN/A187.6766.3713.55Price / SalesN/A16,673.191,276.8487.67Price / CashN/A12.4639.7035.24Price / BookN/A7.886.475.93Net IncomeN/A-$20.05M$119.73M$225.73M7 Day PerformanceN/A7.83%-5.13%-1.34%1 Month PerformanceN/A11.90%-2.71%1.15%1 Year PerformanceN/A31.41%31.08%24.02% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXWCarmellN/A$0.11flatN/AN/A$0.00$12,320.000.009Positive NewsATNFW180 Life SciencesN/A$0.01flatN/A-32.5%$0.00N/A0.007Gap UpSXTPW60 Degrees PharmaceuticalsN/A$0.04flatN/A-26.0%$0.00$418,304.000.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.16-5.8%N/A-37.3%$0.00N/A0.0080News CoverageWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01flatN/A-81.2%$0.00N/A0.0059Short Interest ↓Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.28-3.4%N/A-81.4%$0.00N/A0.008Short Interest ↓Gap DownCDIOWCardio DiagnosticsN/A$0.03-28.2%N/A-63.6%$0.00$39,138.000.007Positive NewsGap UpCELUWCelularityN/A$0.03+66.7%N/A+64.5%$0.00$42.69M0.00220Positive NewsGap UpHigh Trading VolumeCEROWCERo TherapeuticsN/A$0.02+120.5%N/AN/A$0.00N/A0.008Short Interest ↓Positive NewsGap DownHigh Trading VolumeCINGWCingulateN/A$0.05flatN/A+100.0%$0.00N/A0.0013Positive News Related Companies and Tools Related Companies 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Alpha Tau Medical Alternatives Anew Medical Alternatives Apollomics Alternatives BriaCell Therapeutics Alternatives Cardio Diagnostics Alternatives Celularity Alternatives CERo Therapeutics Alternatives Cingulate Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CTCXW) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTCXW Stock Alerts